IPO Rating: City Therapeutics Inc.
✓ IPO Prophet Rating: 7.55/10 🏦 Deal Quality & Underwriters: 8.30/10 City Therapeutics is offering 9.72 million all-primary shares at...
44 Views
City Therapeutics (CTY) Eyes $175 Million IPO to Advance Next-Generation RNAi Medicines
City Therapeutics (CTY) , a Cambridge, Massachusetts-based biotechnology company, plans to list on the Nasdaq Global Market , offering 9,722,222...
46 Views
IPO Rating: Iambic Therapeutics, Inc.
✓ IPO Prophet Rating: 7.83/10 🏦 Deal Quality & Underwriters: 8.35/10 Iambic Therapeutics is offering 9.38 million all-primary shares at...
71 Views
Iambic Therapeutics (IAM) Eyes $150 Million IPO to Advance AI-Designed Cancer Therapies
Iambic Therapeutics (IAM) , a San Diego-based biotechnology company combining artificial intelligence with automated laboratory research, is...
70 Views
U.S. IPO Recap Week of 10/9/2026
Period: Week ended October 9, 2026. Coverage: Traditional U.S. operating-company IPOs of at least $100 million. One qualifying...
70 Views